Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 382,223
  • Shares Outstanding, K 323,918
  • Annual Sales, $ 0 K
  • Annual Income, $ -50,460 K
  • 60-Month Beta 1.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.50
Trade TNXP with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0800 +0.93%
on 04/12/21
1.5900 -31.45%
on 03/17/21
-0.1800 (-14.17%)
since 03/12/21
3-Month
0.8100 +34.57%
on 03/05/21
2.1200 -48.58%
on 02/11/21
+0.1650 (+17.84%)
since 01/12/21
52-Week
0.5100 +113.73%
on 11/10/20
2.4600 -55.69%
on 07/21/20
+0.3720 (+51.81%)
since 04/09/20

Most Recent Stories

More News
Tonix Pharmaceuticals to Present at Needham Virtual Healthcare Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 1.0900 (-7.63%)
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA on TNX-601 CR for the Treatment of Major Depressive Disorder

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has received the official minutes from a Type B pre-investigational...

TNXP : 1.0900 (-7.63%)
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,946,027...

TNXP : 1.0900 (-7.63%)
Further Development of Advanced COVID-19 Diagnostic Testing Continues

PALM BEACH,  Fla., /PRNewswire/ --  While most of the world press has been focused on the vaccine development and implementation, that is not the whole story. Numerable collaborations between governments,...

BIOV.CN : 0.395 (-10.23%)
LMNGF : 0.3170 (-9.43%)
TNXP : 1.0900 (-7.63%)
SVRA : 1.7700 (-9.23%)
ONTX : 0.7171 (-12.72%)
JNJ : 161.64 (+0.24%)
Thinking about buying stock in Tonix Pharmaceuticals, American Resources, CPI Aerostructures, Timber Pharmaceuticals, or Teladoc Health?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TNXP, AREC, CVU, TMBR, and TDOC.

CVU : 4.71 (+0.64%)
TMBR : 1.8900 (-10.85%)
AREC : 3.60 (-3.23%)
TNXP : 1.0900 (-7.63%)
TDOC : 182.01 (+0.41%)
Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission

TNXP : 1.0900 (-7.63%)
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia

TNXP : 1.0900 (-7.63%)
Tonix Pharmaceuticals Achieves 50 Percent Enrollment in RALLY, the Second Phase 3 Study of TNX-102 SL for Management of Fibromyalgia

Enrollment Continues in Phase 3 RALLY Study, with Interim Analysis of the First 50 Percent of Participants Expected Third Quarter 2021

TNXP : 1.0900 (-7.63%)
Tonix Pharmaceuticals to Participate in Upcoming March Investor Conferences

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 1.0900 (-7.63%)
Successful Medical Applications of Psilocybin Help Erode Harmful Stigmas

, /PRNewswire/ -- Scientists and researchers have accomplished numerous notable advancements in biotechnology in recent years. Among the popular fields of study for biotech companies are gene editing,...

PULL.CN : 0.465 (-7.00%)
PRXTF : 0.3706 (-7.35%)
TNXP : 1.0900 (-7.63%)
HSTRF : 0.2675 (-4.46%)
HAVN.CN : 0.770 (+4.05%)
HAVLF : 0.6127 (+5.15%)
CBDT.CN : 0.650 (-8.45%)
EPWCF : 0.5257 (-5.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

3rd Resistance Point 1.2867
2nd Resistance Point 1.2433
1st Resistance Point 1.1667
Last Price 1.0900
1st Support Level 1.0467
2nd Support Level 1.0033
3rd Support Level 0.9267

See More

52-Week High 2.4600
Fibonacci 61.8% 1.7151
Fibonacci 50% 1.4850
Fibonacci 38.2% 1.2549
Last Price 1.0900
52-Week Low 0.5100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar